• Something wrong with this record ?

Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study

M. Bareš, M. Kopeček, T. Novák, P. Stopková, P. Šóš, J .Kožený, M. Brunovský, C. Höschl

. 2009 ; 118 (1-3) : 94-100.

Language English Country Netherlands

Document type Comparative Study, Research Support, Non-U.S. Gov't, Randomized Controlled Trial

Persistent link   https://www.medvik.cz/link/bmc11022352

BACKGROUND: Previous studies have shown effectiveness of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. This double-blind study compared efficacy of l Hz rTMS over the right prefrontal dorsolateral cortex with venlafaxine ER in the treatment of resistant depression. METHODS: A total of 60 inpatients with depressive disorder (DSM-IV criteria), who previously did not respond to at least one antidepressant treatment, were randomly assigned to 1 Hz rTMS with placebo and venlafaxine ER with sham rTMS for 4 weeks. The primary outcome measure was score change in the Montgomery-Asberg Depression Rating Scale (MADRS). We also used Clinical Global Impression (CGI) and Beck Depressive. Inventory-Short Form (BDI-SF). The response was defined as a >or=50% reduction of MADRS score. RESULTS: There were no significant differences between treatment groups in MADRS (p=0.38), BDI-SF (p=0.56) and CGI (p=0.17) scores from baseline to endpoint. Response rates for rTMS (33%) and venlafaxine (39%) as well as remission (MADRS score

000      
03904naa 2200517 a 4500
001      
bmc11022352
003      
CZ-PrNML
005      
20130715115632.0
008      
110729s2009 ne e Eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Bareš, Martin, $d 1965- $7 xx0071354
245    10
$a Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study / $c M. Bareš, M. Kopeček, T. Novák, P. Stopková, P. Šóš, J .Kožený, M. Brunovský, C. Höschl
314    __
$a Prague Psychiatric Centre, Ustavni 91, Prague 8 - Bohnice, 181 03, Czech Republic.
520    9_
$a BACKGROUND: Previous studies have shown effectiveness of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. This double-blind study compared efficacy of l Hz rTMS over the right prefrontal dorsolateral cortex with venlafaxine ER in the treatment of resistant depression. METHODS: A total of 60 inpatients with depressive disorder (DSM-IV criteria), who previously did not respond to at least one antidepressant treatment, were randomly assigned to 1 Hz rTMS with placebo and venlafaxine ER with sham rTMS for 4 weeks. The primary outcome measure was score change in the Montgomery-Asberg Depression Rating Scale (MADRS). We also used Clinical Global Impression (CGI) and Beck Depressive. Inventory-Short Form (BDI-SF). The response was defined as a >or=50% reduction of MADRS score. RESULTS: There were no significant differences between treatment groups in MADRS (p=0.38), BDI-SF (p=0.56) and CGI (p=0.17) scores from baseline to endpoint. Response rates for rTMS (33%) and venlafaxine (39%) as well as remission (MADRS score<or=10 points) rates (19% vs. 23%) and drop-out rate did not differ between treatment groups. There were significant reductions of MADRS, CGI and BDI-SF scores in both groups. LIMITATIONS: Small sample size. No placebo arm was included for ethical reasons, because both treatments have previously been reported to be more effective than placebo. Relatively short duration of antidepressant treatment. CONCLUSION: The findings of this study suggest that, at least in the acute treatment, the right sided rTMS produces clinically relevant reduction of depressive symptomatology in patients with resistant depression comparable to venlafaxine ER. Larger sample sizes are required to confirm these results.
590    __
$a bohemika - dle Pubmed
650    _2
$a dospělí $7 D000328
650    _2
$a antidepresiva druhé generace $x škodlivé účinky $x terapeutické užití $7 D018687
650    _2
$a cyklohexanoly $x škodlivé účinky $x terapeutické užití $7 D003511
650    _2
$a depresivní porucha unipolární $x diagnóza $x patofyziologie $x psychologie $x terapie $7 D003865
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a testování osobnosti $x statistika a číselné údaje $7 D010552
650    _2
$a prefrontální mozková kůra $x patofyziologie $x účinky léků $7 D017397
650    _2
$a psychometrie $7 D011594
650    _2
$a transkraniální magnetická stimulace $7 D050781
655    _2
$a srovnávací studie $7 D003160
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Kopeček, Miloslav, $d 1972- $7 js20070525003
700    1_
$a Novák, Tomáš, $d 1975- $7 xx0079061
700    1_
$a Stopková, Pavla, $d 1971- $7 mzk2008430635
700    1_
$a Šóš, Peter $7 xx0105367
700    1_
$a Kožený, Jiří, $d 1938- $7 nlk20030130453
700    1_
$a Brunovský, Martin, $7 xx0070660 $d 1975-
700    1_
$a Höschl, Cyril, $d 1949- $7 jn20000401149
773    0_
$t Journal of Affective Disorders $w MED00002501 $g Roč. 118, č. 1-3 (2009), s. 94-100 $x 0165-0327
910    __
$a ABA008 $b x $y 2
990    __
$a 20110801145702 $b ABA008
991    __
$a 20130715120101 $b ABA008
999    __
$a ok $b bmc $g 881743 $s 732271
BAS    __
$a 3
BMC    __
$a 2009 $x MED00002501 $b 118 $c 1-3 $d 94-100 $m Journal of affective disorders $n J Affect Disord $i 0165-0327
LZP    __
$a 2011-4B09/jvme

Find record

Citation metrics

Archiving options